About Us
Company Introduction Strategic Development Social Responsibility
Scientific Research
Innovative Layout Innovative Field
International
Global Expansion Cooperative Partner Global R&D Centers International Cooperation
Investor Relations
Information Disclosure Corporate Governance Stock Information ESG Contact us
Products Services
Product center Product branding Quality & Safety
News
Company News Media Coverage Media Inquiries Multimedia zone
Career
Talent R&D Team Employee Life Job Opportunities
EN
CN
About Us
· Company Introduction · Strategic Development · Social Responsibility
Scientific Research
· Innovative Layout · Innovative Field
Products Services
· Product center · Product branding · Quality & Safety
News
· Company News · Media Coverage · Media Inquiries · Multimedia zone
Vocational
· Concept about Talent · R&D Team · Employee Life · Job Opportunities
> News > Company
Return
Chengdu Purevalley Medical Technology New Construction Project of Radionuclide Temporary Storage Workplace Environmental Impact Assessment Report Sheet Full Public Notice
2024-08-08

Chengdu Purevalley Medical Technology Co., Ltd. has basically completed the preparation of the environmental impact report form for the construction project of new radionuclide temporary storage workplace.

According to the “Guidelines for Disclosure of Government Information on Environmental Impact Assessment of Construction Projects” (for trial implementation) issued by the Ministry of Environmental Protection, we hereby inform you of the way to publicize the environmental impact report form (full text) of the project.

1. Method and period of public access to the full text of the environmental impact report form

Within 10 working days from the date of this public notice, the public can obtain the full text of the report table through the following website

2. Scope of public comments

The scope of the public consultation is the public’s opinion on the full text of “New Radionuclide Temporary Storage Workplace Construction Project of Chengdu Pulweiye Medical Technology Co.

3. Specific forms of soliciting public opinions

The public can take e-mail, telephone and postal mail and other ways to express their views, the construction unit and the environmental impact assessment organization will be based on the public comments in the final environmental impact report form to give instructions for adoption or not.

4. Contact Information

The construction unit of the project: Chengdu Pulwell Medical Technology Co.

Contact person, contact phone number, e-mail:

Mr. Zhang 15901000861 zhangyang01@grandpharma.cn

② undertake the evaluation of the environmental impact assessment agency: Sichuan Natural Resources Experimental Testing and Research Center (Sichuan Nuclear Emergency Technical Support Center)

Contact person, contact number, e-mail:

Ms. Liao 028-84200104 986024483@admin

Prev

Next

Related news

  • <em>The Phase IIa Clinical Study Conducted in China of Grand Pharma’s Global Innovative Ophthalmic Drug GPN00884 Has Completed the First Patient Enrollment</em>
    The Phase IIa Clinical Study Conducted in China of Grand Pharma’s Global Innovative Ophthalmic Drug GPN00884 Has Completed the First Patient Enrollment

    2025-10-26

  • The Registration Clinical Study Conducted in China of the Global Innovative Temperature-Sensitive Embolic Agent Has Completed All Patients Enrollment
    The Registration Clinical Study Conducted in China of the Global Innovative Temperature-Sensitive Embolic Agent Has Completed All Patients Enrollment

    2025-10-09

  • Grand Pharma’s Treprostinil Injection Has Been Granted a Drug Registration Certificate by NMPA
    Grand Pharma’s Treprostinil Injection Has Been Granted a Drug Registration Certificate by NMPA

    2025-09-24

Grand Pharma Group
About Us
Company Introduction Strategic Development Social Responsibility
Scientific Research
Innovative Layout Innovative Field
International
Global expansion Cooperative Partner Global R&D Centers International Cooperation
Investor Relations
Information Disclosure Corporate Governance Stock Information Contact us
Products Services
Product Center Product branding Quality & Safety
News
Company News Media Coverage Media Inquiries Multimedia zone
Vocational
Concept about Talent R&D Team Employee Life Job Opportunities
Copyright © Grand Pharma (China) Co., Ltd. All Rights Reserved E ICP B 10008288 EGWAB 42010402000597
Legal Provisions